SCHEMBL21389132

SCHEMBL21389132

CC1(C)CCN(CCO)C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PER2 O15055 2/20 0.40
CRY2 Q49AN0 2/20 0.40
EHMT2 Q96KQ7 3/20 0.39
OPRM1 P35372 3/20 0.35
OPRD1 P41143 3/20 0.35
OPRK1 P41145 2/20 0.35
OPRL1 P41146 2/20 0.35
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
RECQL P46063 1/20 0.34
BLM P54132 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21389411 0.89 PER2 (0.43) PER2CRY2EHMT2OPRM1OPRD1
SCHEMBL28648812 0.82 PER2 (0.38) PER2CRY2EHMT2OPRM1OPRD1
SCHEMBL27743133 0.80 PER2 (0.37) PER2CRY2EHMT2OPRM1OPRD1
Ammonia Solution, Strong SCHEMBL8031383 0.80 PER2 (0.37) PER2CRY2EHMT2OPRM1OPRD1
SCHEMBL27602897 0.78 OPRM1 (0.45) PER2CRY2EHMT2OPRM1OPRD1
SCHEMBL21389136 0.78 MEN1 (0.32) OPRM1OPRD1OPRK1OPRL1KMT2A
SCHEMBL13432030 0.77 PER2 (0.35) PER2CRY2EHMT2OPRM1OPRD1
SCHEMBL16703117 0.77 PER2 (0.39) PER2CRY2EHMT2OPRM1OPRD1
Hydrochloric Acid SCHEMBL3387668 0.76 PER2 (0.35) PER2CRY2EHMT2OPRM1OPRD1
SCHEMBL28465414 0.76 RARB (0.43) OPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-11-09 US disclosed
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-11-09 US disclosed
US-11535660-B1 Modulators of G-protein coupled receptors Cannot Therapeutics, Inc. (US) 2022-12-27 US disclosed
WO-2019183577-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. (US) 2019-09-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR PER2 1938/4885CRY2 2561/4885EHMT2 2346/4885
US-11535660-B1 Modulators of G-protein coupled receptors GIPR, GLP1R, GCGR PER2 2034/4885CRY2 2693/4885EHMT2 2198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.